Alto Neuroscience, Inc.
ANRO
$3.61
-$0.27-6.96%
NYSE
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | -23.58% | -21.92% | 103.80% | 254.28% | -- |
Total Receivables | -- | -- | -- | -- | -- |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | 5.46% | 21.24% | 106.51% | 143.40% | -- |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -84.67% | -98.71% | 136.75% | -- |
Total Current Assets | -23.32% | -21.50% | 98.31% | 252.60% | -- |
|
|||||
Total Current Assets | -23.32% | -21.50% | 98.31% | 252.60% | -- |
Net Property, Plant & Equipment | 382.73% | 371.24% | 525.59% | 667.78% | -- |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 112.30% | 1,743.10% | 8,300.00% | 150.75% | -- |
Total Assets | -20.01% | -18.11% | 104.95% | 259.92% | -- |
|
|||||
Total Accounts Payable | -9.33% | -42.62% | 47.02% | 28.25% | -- |
Total Accrued Expenses | -3.48% | 22.10% | 116.28% | 95.73% | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | -58.01% | -27.06% | 596.00% | 2,043.94% | -- |
Total Finance Division Other Current Liabilities | -- | -92.50% | -- | -- | -- |
Total Other Current Liabilities | -- | -92.50% | -- | -- | -- |
Total Current Liabilities | -17.41% | -9.36% | 78.40% | 134.36% | -- |
|
|||||
Total Current Liabilities | -17.41% | -9.36% | 78.40% | 134.36% | -- |
Long-Term Debt | 159.94% | 140.02% | 17.21% | -32.07% | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | -- | -- | -- |
Total Liabilities | 96.00% | 95.14% | 68.59% | 68.77% | -- |
|
|||||
Common Stock & APIC | 2.93% | 3.20% | 5,297.56% | 5,987.02% | -- |
Retained Earnings | -60.95% | -69.91% | -79.82% | -87.37% | -- |
Treasury Stock & Other | 134.83% | 116.67% | -27.85% | -10.47% | -- |
Total Common Equity | -31.35% | -27.97% | 311.32% | 370.15% | -- |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | -31.35% | -27.97% | 311.32% | 370.15% | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | -31.35% | -27.97% | 112.85% | 340.12% | -- |
|